Characterization and Predictors of Fractures Following Hematopoietic Stem Cell Transplantation
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae042 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Hsin-Lin Tsai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 112201, Taiwan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Fractures, Bone. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Yen Tjing Ling Medical Foundation.
Abstract (Originalsprache)
Context
Bone loss and fractures are common and serious complications following hematopoietic stem cell transplantation (HSCT), and identifying risk predictors for fractures in transplant recipients remains challenging. The Taiwan Bone Marrow Donation Center is the largest databank of donors in Asia. However, no population-based studies have yet been conducted in Asia to accurately assess the risk of fractures.
Objective
The aims of this study were to determine the incidence and risk factors for fractures in HSCT recipients.
Methods
We conducted a retrospective cohort study of patients older than 18 years who received a HSCT from January 1, 2003 to September 30, 2015, using the Taiwan National Health Insurance Research Database. Fractures following HSCT were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Cox regression analysis was used to identify risk factors for fractures.
Results
A total of 3327 patients underwent a HSCT, of whom 126 (3.8%) had a fracture after HSCT. The cumulative incidence of fractures was 5.3% at 5 years, and 10.8% at 10 years. Multivariable analysis showed that a fracture in the 3 years prior to transplant (HR = 3.79; 95% CI, 2.39-6.03) was associated with a higher risk of fractures post HSCT. With a daily dose equivalent of more than 0.50-3.75 mg, more than 3.75-15.23 mg, and more than 15.23 mg prednisolone, the risk of fractures increased by 1.70-fold (95% CI, 1.07-2.71), 2.23-fold (95% CI 1.32-3.76), and 2.93-fold (95% CI, 1.43-6.01), respectively.
Conclusion
Regular screening to monitor bone loss should be initiated early, and counseling about the importance of general preventive measures for bone loss is warranted in HSCT recipients with a prior fracture and mean daily dose of steroids more than 0.50 mg.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 112201, Taiwan.
- Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
- Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 112201, Taiwan.
- Department of Pediatrics, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
- Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
ORCID-Profile: Hsin-Lin Tsai, Hui-Hsin Yang, Jei-Wen Chang
Förderung
- Yen Tjing Ling Medical Foundation
Zitieren
APA
Tsai, H. L., Lin, T. C., Yang, H. H., & Chang, J. W. (2024). Characterization and Predictors of Fractures Following Hematopoietic Stem Cell Transplantation. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae042
Vancouver
Tsai HL, Lin TC, Yang HH, Chang JW. Characterization and Predictors of Fractures Following Hematopoietic Stem Cell Transplantation. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae042
BibTeX
@article{Tsai2024,
author = {Tsai, Hsin-Lin and Lin, Tzu-Ching and Yang, Hui-Hsin and Chang, Jei-Wen},
title = {Characterization and Predictors of Fractures Following Hematopoietic Stem Cell Transplantation},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae042}
}
EUVIMED